Chemours Co
11 nominees · 4 ballot items.
Election of eleven directors; advisory (non-binding) vote to approve named executive officer compensation; approval of the Chemours Company 2026 Equity and Incentive Plan; ratification of PricewaterhouseCoopers LLP as independent auditors.
Follow how the vote landed and what changed on Chemours Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElect eleven director nominees named in the proxy statement to serve one-year terms until the 2027 annual meeting.
- 2
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.
- 3
Approval of The Chemours Company 2026 Equity and Incentive Plan
ManagementBoard: FORApprove the 2026 Equity and Incentive Plan to reserve 6,375,275 shares for awards and allow continued equity compensation to employees, directors and consultants.
- 4
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the Audit Committee’s selection of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for fiscal year 2026.
Nominees on the ballot11
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.5% | 15,813,238 | $348M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.9% | 10,325,341 | $227M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 6,773,917 | $149M |
| 4 | STATE STREET CORP | 4.1% | 6,123,088 | $135M |
| 5 | AMERIPRISE FINANCIAL INC | 3.2% | 4,739,228 | $104M |
| 6 | BlackRock, Inc. | 2.9% | 4,420,710 | $97M |
| 7 | AMERICAN CENTURY COMPANIES INC | 2.9% | 4,415,864 | $97M |
| 8 | Wolf Hill Capital Management, LP | 2.5% | 3,689,794 | $81M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.0% | 3,074,437 | $68M |
| 10 | JPMORGAN CHASE CO | 2.0% | 3,055,950 | $65M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at Chemours Co’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Chemours Co 2026 annual meeting?
- Chemours Co (CC) holds its 2026 annual shareholder meeting on Friday, April 24, 2026.
- What is the record date for the Chemours Co 2026 meeting?
- The record date for the Chemours Co 2026 meeting is Monday, March 2, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Chemours Co's 2026 meeting?
- The board is presenting 11 director nominees at the Chemours Co 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Chemours Co 2026 meeting?
- Shareholders will vote on 4 proposals at the Chemours Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.